CPI joins the Sustainable Medicines Partnership

YewMaker, the executive lead of the Sustainable Medicines Partnership (SMP), is announcing that CPI has joined as a founding Collaborator.

The SMP is a not-for-profit private-public collaboration executing projects to make the use of medicines more sustainable and less wasteful.

CPI accelerates the development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions, including next-generation medicine manufacturing innovations, offering world-leading facilities and expertise in small molecules, biologics, and complex medicines.

Home to the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, CPI is creating agile, efficient, and sustainable supply chains by convening actors across the pharma industry ecosystem in a pre-competitive space and boosting adoption of industry 4.0 digitisation.

In its collaboration with the SMP, the CPI-led Medicines Manufacturing Innovation Centre will help the global pharma ecosystem adopt novel technologies and processes to improve the sustainability of medicines, their manufacturing and associated supply chains. 

We’re excited to join the SMP as we have a shared vision, to improve sustainability through innovation. CPI’s technical programmes and Grand Challenges are helping to bring new pharma innovations to market, and to reduce costs and waste within the industry. CPI, alongside SMP and its wide set of collaborators will provide a significant impact to the sustainability of medicines globally and in the UK.
— Dave Tudor, Managing Director of the CPI-led Medicines Manufacturing Innovation Centre
We are thrilled CPI have joined the SMP. CPI is a trusted partner of industry, academia, government, and the investment community with a long track record of turning ideas into reality and a strong commitment to sustainable medicines manufacturing solutions. We look forward to working together.
— Nazneen Rahman, YewMaker CEO, SMP Director

Posted 24/08/22

-End

 

Contacts:

YewMaker: comms@yewmaker.com

CPI: alex.cole@uk-cpi.com

About the Sustainable Medicines Partnership
The SMP is a not-for-profit, private-public, multi-stakeholder collaboration. Through executing priority actions, the Sustainable Medicines Partnership aims to stop the avoidable waste of medicines and medicines packaging - reducing healthcare emissions and increasing health equity globally. Learn more at www.yewmaker.com/smp

About YewMaker
YewMaker builds science-based, scalable concepts and solutions that make healthcare more sustainable. YewMaker is the initiator and executive lead of the Sustainable Medicines Partnership. Learn more at www.yewmaker.com

About CPI
Learn CPI connects the dots within the innovation ecosystem to make great ideas and inventions a reality to benefit people, places and planet. We’re a pioneering social enterprise that accelerates the development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions. Through our innovation experts and infrastructure, we look beyond the obvious to transform healthcare and drive towards a sustainable future.

As a trusted partner of industry, academia, government, and the investment community, we’re the catalyst for delivering smart AgriFoodTech, energy storage, HealthTech, materials, and pharma innovations. We believe by working together we can build a better collective future, and as part of the High Value Manufacturing Catapult, we facilitate access to world-class organisations to deliver transformation across industries.

Creating lasting global impact from the North of England and Scotland, we invest in people and disruptive technologies to invigorate economies, create circular supply chains and make our world a better place. Learn more at uk-cpi.com

About the Medicines Manufacturing Innovation Centre
The Medicines Manufacturing Innovation Centre is a collaboration between CPI, University of Strathclyde, UK Research & Innovation, Scottish Enterprise and founding industry partners, AstraZeneca and GSK.

The centre will ensure the UK is a technology and innovation leader in pharmaceutical manufacturing. The initial focus will be on technology translation for small molecule drug manufacture. Learn more at: https://www.uk-cpi.com/about/national-centres/medicines-manufacturing-innovation-centre

 

 

Previous
Previous

GS1 Healthcare joins the Sustainable Medicines Partnership

Next
Next

NW Greener NHS joins the Sustainable Medicines Partnership